logo

For the Inventor, By the Inventor

Wülfrath, Germany

Barbara Albrecht-Küpper

This inventor holds 20 USPTO granted patents and 3 published patent applications and 17 EPO patents. Top assignees: Bayer Intellectual Property Gmbh, Bayer Animal Health Gmbh, Bayer Schering Pharma Ag. Active years: 2012-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Barbara Albrecht-Küpper. Retrieved from https://idiyas.com/inventor/barbara-albrecht-küpper

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 20 

% Patents Active = 20.0

 

Average Co-Inventor Count = 7.6

ph-index = 5

Forward Citations = 59(Granted Patents)


Location History:

  • Wüfrath, DE (2014)
  • Wulfrath, DE (2014)
  • Wülfrath, DE (2012 - 2015)

Company Filing History:

goldMedal18 out of 721 
 
Bayer Intellectual Property Gmbh
 patents
silverMedal1 out of 54 
 
Bayer Animal Health Gmbh
 patents
bronzeMedal1 out of 192 
 
Bayer Schering Pharma Ag
 patents

Years Active: 2012-2015

Loading Chart...
Loading Chart...
20 patents (USPTO):Explore Patents
1. 9205077 - 2-alkoxy-substituted dicyanopyridines and their use (2015-12-08),
2. 9095582 - Substituted aryloxazoles and their use (2015-08-04),
3. 9051316 - Substituted 4-aryl-1,4-dihydro-1,6-naphthyridine amides and their use (2015-06-09),
4. 9040566 - Adenosine A1 agonists for the treatment of glaucoma and ocular hypertension (2015-05-26),
5. 8957017 - Dipeptoid prodrugs and their use (2015-02-17),
6. 8791146 - 2-alkoxy-substituted dicyanopyridines and their use (2014-07-29),
7. 8772498 - Alkylamine-substituted dicyanopyridine and amino acid ester prodrugs thereof (2014-07-08),
8. 8741834 - Dipeptoid prodrugs and the use thereof (2014-06-03),
9. 8703934 - Substituted 4-amino-3,5-dicyano-2-thiopyridines and use thereof (2014-04-22),
10. 8703696 - Dipeptoid prodrugs and the use thereof (2014-04-22),
11. 8653109 - Substituted bipyridine derivatives and their use as adenosine receptor ligands (2014-02-18),
12. 8618119 - Fused cyanopyridines and the use thereof (2013-12-31),
13. 8609686 - Substituted azabicyclic compounds and the use thereof (2013-12-17),
14. 8440700 - Substituted aryloxazoles and their use (2013-05-14),
15. 8436180 - Substituted-4-aryl-1,4-dihydro-1,6-naphthyridinamides and use thereof (2013-05-07),

Title: A Closer Look at Barbara Albrecht-Küpper: Innovator in Medicinal Chemistry

Introduction

Barbara Albrecht-Küpper, based in Wülfrath, Germany, is a prominent figure in the field of medicinal chemistry with an impressive portfolio of 20 patents. Her work focuses primarily on developing novel therapeutic compounds, especially for treating cardiovascular and metabolic disorders.

Latest Patents

Among her latest innovations are two significant patents. The first is titled "2-alkoxy-substituted dicyanopyridines and their use," which explores new compounds and methods for treating and preventing diseases, particularly cardiovascular disorders. The second patent, "Substituted aryloxazoles and their use," also focuses on novel derivatives aimed at treating cardiovascular and metabolic diseases. Both patents demonstrate her commitment to advancing medical treatments through innovative chemical solutions.

Career Highlights

Barbara has had a distinguished career working with esteemed organizations such as Bayer Intellectual Property GmbH and Bayer Schering Pharma AG. Her experience in these companies has significantly contributed to her expertise in patent law and the commercialization of innovations in pharmaceuticals.

Collaborations

Throughout her career, Barbara has collaborated with notable professionals in the field. Two of her esteemed coworkers include Peter Nell and Alexandros Vakalopoulos, with whom she has likely worked on various projects and patent applications, sharing insights and expertise in their respective areas of research.

Conclusion

Barbara Albrecht-Küpper stands out as a leading inventor in the field of medicinal chemistry. With her substantial contributions through patents and collaborative efforts, she continues to push the boundaries of innovation in the treatment of critical health conditions. Her work not only enhances our understanding of medicinal compounds but also opens new avenues for effective therapies, contributing to the betterment of global health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…